Also, METTL3 has been demonstrated to inhibit RAD52 Motif Containing 1 (RDM1) mRNA expression in an m6A-dependent manner, thereby ultimately promoting the growth of HCC cells via repression of p53 signaling pathway (Chen S. L. et al., 2020). Here, METTL3 is linked to hepatocellular carcinoma.